154 related articles for article (PubMed ID: 26704932)
1. Beyond a tumor suppressor: Soluble E-cadherin promotes the progression of cancer.
Hu QP; Kuang JY; Yang QK; Bian XW; Yu SC
Int J Cancer; 2016 Jun; 138(12):2804-12. PubMed ID: 26704932
[TBL] [Abstract][Full Text] [Related]
2. Overview on the Role of E-Cadherin in Gastric Cancer: Dysregulation and Clinical Implications.
Zhao H; Hu H; Chen B; Xu W; Zhao J; Huang C; Xing Y; Lv H; Nie C; Wang J; He Y; Wang SQ; Chen XB
Front Mol Biosci; 2021; 8():689139. PubMed ID: 34422902
[TBL] [Abstract][Full Text] [Related]
3. Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT-like phenotype change and MMP-9-mediated degradation of E-cadherin.
Zuo JH; Zhu W; Li MY; Li XH; Yi H; Zeng GQ; Wan XX; He QY; Li JH; Qu JQ; Chen Y; Xiao ZQ
J Cell Biochem; 2011 Sep; 112(9):2508-17. PubMed ID: 21557297
[TBL] [Abstract][Full Text] [Related]
4. The genesis and unique properties of the lymphovascular tumor embolus are because of calpain-regulated proteolysis of E-cadherin.
Ye Y; Tian H; Lange AR; Yearsley K; Robertson FM; Barsky SH
Oncogene; 2013 Mar; 32(13):1702-13. PubMed ID: 22580607
[TBL] [Abstract][Full Text] [Related]
5. The mechanism and significance of E-cadherin, anti-apoptosis B-cell lymphoma-2 protein and sE-cadherin roles in cancer.
Liu L; Li HX; Lv XQ
J Biol Regul Homeost Agents; 2014; 28(4):683-91. PubMed ID: 25620178
[TBL] [Abstract][Full Text] [Related]
6. Downregulation in vivo of the invasion-suppressor molecule E-cadherin in experimental and clinical cancer.
Mareel M; Vleminckx K; Vermeulen S; Yan G; Bracke M; van Roy F
Princess Takamatsu Symp; 1994; 24():63-80. PubMed ID: 8983064
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of MMPs by soluble E-cadherin in human lung tumor cells.
Nawrocki-Raby B; Gilles C; Polette M; Bruyneel E; Laronze JY; Bonnet N; Foidart JM; Mareel M; Birembaut P
Int J Cancer; 2003 Jul; 105(6):790-5. PubMed ID: 12767064
[TBL] [Abstract][Full Text] [Related]
8. Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis.
Oka H; Shiozaki H; Kobayashi K; Inoue M; Tahara H; Kobayashi T; Takatsuka Y; Matsuyoshi N; Hirano S; Takeichi M
Cancer Res; 1993 Apr; 53(7):1696-701. PubMed ID: 8453644
[TBL] [Abstract][Full Text] [Related]
9. Circulating soluble E-cadherin levels are of prognostic significance in patients with multiple myeloma.
Syrigos KN; Harrington KJ; Karayiannakis AJ; Baibas N; Katirtzoglou N; Roussou P
Anticancer Res; 2004; 24(3b):2027-31. PubMed ID: 15274395
[TBL] [Abstract][Full Text] [Related]
10. The predictive value of serum soluble E-cadherin levels in breast cancer patients undergoing preoperative systemic chemotherapy.
Hofmann G; Balic M; Dandachi N; Resel M; Schippinger W; Regitnig P; Samonigg H; Bauernhofer T
Clin Biochem; 2013 Oct; 46(15):1585-9. PubMed ID: 23792261
[TBL] [Abstract][Full Text] [Related]
11. Plasmin produces an E-cadherin fragment that stimulates cancer cell invasion.
Ryniers F; Stove C; Goethals M; Brackenier L; Noë V; Bracke M; Vandekerckhove J; Mareel M; Bruyneel E
Biol Chem; 2002 Jan; 383(1):159-65. PubMed ID: 11928810
[TBL] [Abstract][Full Text] [Related]
12. The clinical significance of soluble E-cadherin in nonsmall cell lung cancer.
Charalabopoulos K; Gogali A; Dalavaga Y; Daskalopoulos G; Vassiliou M; Bablekos G; Karakosta A; Constantopoulos S
Exp Oncol; 2006 Mar; 28(1):83-5. PubMed ID: 16614715
[TBL] [Abstract][Full Text] [Related]
13. Levels of soluble E-cadherin in breast, gastric, and colorectal cancers.
Repetto O; De Paoli P; De Re V; Canzonieri V; Cannizzaro R
Biomed Res Int; 2014; 2014():408047. PubMed ID: 25535613
[TBL] [Abstract][Full Text] [Related]
14. Formation of E-cadherin-mediated cell-cell adhesion activates AKT and mitogen activated protein kinase via phosphatidylinositol 3 kinase and ligand-independent activation of epidermal growth factor receptor in ovarian cancer cells.
Reddy P; Liu L; Ren C; Lindgren P; Boman K; Shen Y; Lundin E; Ottander U; Rytinki M; Liu K
Mol Endocrinol; 2005 Oct; 19(10):2564-78. PubMed ID: 15928314
[TBL] [Abstract][Full Text] [Related]
15. New insights into the role of soluble E-cadherin in tumor angiogenesis.
Tang MKS; Ip PP; Wong AST
Cell Stress; 2018 Aug; 2(9):236-238. PubMed ID: 31225492
[TBL] [Abstract][Full Text] [Related]
16. Tumor progression: the role of cadherins and integrins.
Glukhova M; Deugnier MA; Thiery JP
Mol Med Today; 1995 May; 1(2):84-9. PubMed ID: 17607900
[TBL] [Abstract][Full Text] [Related]
17. Soluble E-cadherin: more than a symptom of disease.
Grabowska MM; Day ML
Front Biosci (Landmark Ed); 2012 Jan; 17(5):1948-64. PubMed ID: 22201848
[TBL] [Abstract][Full Text] [Related]
18. Cross-talk between EGFR and T-cadherin: EGFR activation promotes T-cadherin localization to intercellular contacts.
Kyriakakis E; Maslova K; Frachet A; Ferri N; Contini A; Pfaff D; Erne P; Resink TJ; Philippova M
Cell Signal; 2013 May; 25(5):1044-53. PubMed ID: 23411345
[TBL] [Abstract][Full Text] [Related]
19. Extracellular cleavage of E-cadherin promotes epithelial cell extrusion.
Grieve AG; Rabouille C
J Cell Sci; 2014 Aug; 127(Pt 15):3331-46. PubMed ID: 24895403
[TBL] [Abstract][Full Text] [Related]
20. A comprehensive analysis of different types of databases reveals that CDH1 mRNA and E-cadherin protein are not downregulated in most carcinoma tissues and carcinoma cell lines.
Sicairos B; Alam S; Du Y
BMC Cancer; 2023 May; 23(1):441. PubMed ID: 37189027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
